There have been 7 recent insider transactions recorded for Lotus Pharmaceuticals, Inc. (LTUS), including 4 buys and 2 sells. Total insider buying was valued at $224.1K and total insider selling at RSU Award.
Notable insiders with recent activity include Wasserman Adam C, Nierenberg David. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — LTUS
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2007-08-21 |
Wasserman Adam C |
CFO |
Other (Buy) |
50,000 |
$0.55 |
$27.5K |
94,200 |
| 2007-05-31 |
Wasserman Adam C |
CFO |
Other (Buy) |
44,200 |
$1.00 |
$44.2K |
44,200 |
| 2004-01-06 |
Nierenberg David |
10 Percent Owner |
Other (Sell) |
25,000 |
- |
- |
948,375 |
| 2003-08-25 |
Nierenberg David |
10 Percent Owner |
Other (Sell) |
41,700 |
- |
- |
- |
| 2003-05-01 |
Nierenberg David |
10 Percent Owner |
Unknown |
- |
- |
- |
- |
| 2002-11-22 |
Nierenberg David |
10 Percent Owner |
Informative Buy |
7,500 |
$11.28 |
$84.6K |
17,500 |
| 2001-10-18 |
Nierenberg David |
10 Percent Owner |
Informative Buy |
10,000 |
$6.78 |
$67.8K |
10,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
